المؤلفون: Ferro Sánchez, Lucía

المساهمون: University/Department: Universitat de les Illes Balears. Doctorat en Investigació Translacional en Salut Pública i Malalties d'Alta Prevalença

Thesis Advisors: de Villalonga Smith, Priam

المصدر: TDX (Tesis Doctorals en Xarxa)

مصطلحات موضوعية: Glioblastoma, Tractament, Mitosi, Clorpromazina, Temozolomida, Tratamiento, Mitosis, Treatment, Clorpromazine, Temozolomide, Medicina Oncològica

وصف الملف: application/pdf

URL الوصول: http://hdl.handle.net/10803/691429

المؤلفون: Pawlak, Wiktoria¹ (AUTHOR) wiktoria.pawlak199@gmail.com, Majchrzak-Celińska, Aleksandra¹ (AUTHOR) majchrzakcelinska@ump.edu.pl

المصدر: International Journal of Molecular Sciences. Jan2025, Vol. 26 Issue 2, p661. 15p.

مصطلحات موضوعية: *GLIOMAS, *TEMOZOLOMIDE, *ASTROCYTOMAS, *GLIOBLASTOMA multiforme, *CYTOTOXINS

المؤلفون: Kanamori, Masayuki¹ (AUTHOR) mkanamori@med.tohoku.ac.jp, Shibahara, Ichiyo² (AUTHOR), Shimoda, Yoshiteru¹ (AUTHOR), Akiyama, Yukinori³ (AUTHOR), Beppu, Takaaki⁴ (AUTHOR), Ohba, Shigeo⁵ (AUTHOR), Enomoto, Toshiyuki⁶ (AUTHOR), Ono, Takahiro⁷ (AUTHOR), Mitobe, Yuta⁸ (AUTHOR), Hanihara, Mitsuto⁹ (AUTHOR), Mineharu, Yohei¹⁰ (AUTHOR), Ishida, Joji¹¹ (AUTHOR), Asano, Kenichiro¹² (AUTHOR), Yoshida, Yasuyuki¹³ (AUTHOR), Natsumeda, Manabu¹⁴ (AUTHOR), Nomura, Sadahiro¹⁵ (AUTHOR), Abe, Tatsuya¹⁶ (AUTHOR), Yonezawa, Hajime¹⁷ (AUTHOR), Katakura, Ryuichi¹⁸ (AUTHOR), Shibui, Soichiro¹⁹ (AUTHOR)

المصدر: International Journal of Clinical Oncology. Jan2025, Vol. 30 Issue 1, p51-61. 11p.

مصطلحات موضوعية: *CONTRAST-enhanced magnetic resonance imaging, *TEMOZOLOMIDE, *OVERALL survival, *BEVACIZUMAB, *STROKE

المؤلفون: Yi, Linbin¹ (AUTHOR), Zhang, Zhenyu² (AUTHOR), Zhou, Wenjie^3,4 (AUTHOR), Zhang, Yunchu¹ (AUTHOR), Hu, Yuzhu¹ (AUTHOR), Guo, Anjie¹ (AUTHOR), Cheng, Yongzhong¹ (AUTHOR), Qian, Zhiyong¹ (AUTHOR), Zhou, Peizhi¹ (AUTHOR) peizhizhouns@126.com, Gao, Xiang¹ (AUTHOR) xianggao@scu.edu.cn

المصدر: Advanced Science. 12/26/2024, Vol. 11 Issue 48, p1-20. 20p.

مصطلحات موضوعية: *GENETIC transcription, *TEMOZOLOMIDE, *GLIOMAS, *DRUG resistance, *TREATMENT effectiveness

المؤلفون: Sunday, Emmanuel Garba¹ emistocrate@yahoo.com, Sunday, Eno-Abasi Garba², Ukachukwu, Alvan-Emeka K.³, Bankole, Nourou Dine Adeniran⁴

المصدر: Romanian Neurosurgery. Dec2024, Vol. 38 Issue 4, p437-443. 7p.

مصطلحات موضوعية: *RESOURCE-limited settings, *TEMOZOLOMIDE, *GLIOMAS, *DIAGNOSIS, *TUMORS

المؤلفون: Woo, Peter Y. M.¹ (AUTHOR) wym307@ha.org.hk, Law, Tiffany H. P.¹ (AUTHOR), Lee, Kelsey K. Y.¹ (AUTHOR), Chow, Joyce S. W.² (AUTHOR), Li, Lai-Fung³ (AUTHOR), Lau, Sarah S. N.³ (AUTHOR), Chan, Tony K. T.⁴ (AUTHOR), Ho, Jason M. K.⁵ (AUTHOR), Lee, Michael W. Y.⁶ (AUTHOR), Chan, Danny T. M.⁷ (AUTHOR), Poon, Wai-Sang⁷ (AUTHOR)

المصدر: British Journal of Neurosurgery. Dec2024, Vol. 38 Issue 6, p1381-1389. 9p.

مصطلحات موضوعية: *GLIOBLASTOMA multiforme, *TEMOZOLOMIDE, *OVERALL survival, *LOG-rank test, TUMOR surgery

المؤلفون: Lucas, Calixto-Hope G, Al-Adli, Nadeem N, Young, Jacob S, Gupta, Rohit, Morshed, Ramin A, Wu, Jasper, Ravindranathan, Ajay, Shai, Anny, Oberheim Bush, Nancy Ann, Taylor, Jennie W, de Groot, John, Villanueva-Meyer, Javier E, Pekmezci, Melike, Perry, Arie, Bollen, Andrew W, Theodosopoulos, Philip V, Aghi, Manish K, Chang, Edward F, Hervey-Jumper, Shawn L, Raleigh, David R, Molinaro, Annette M, Costello, Joseph F, Diaz, Aaron A, Clarke, Jennifer L, Butowski, Nicholas A, Phillips, Joanna J, Chang, Susan M, Berger, Mitchel S, Solomon, David A

المصدر: Neuro-Oncology. 27(1)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Neurosciences, Human Genome, Orphan Drug, Cancer Genomics, Genetics, Cancer, Brain Disorders, Rare Diseases, Brain Cancer, 2.1 Biological and endogenous factors, DNA methylation, glioblastoma, gliosarcoma, molecular neuropathology, temozolomide-induced hypermutation, Humans, Glioblastoma, Isocitrate Dehydrogenase, Brain Neoplasms, DNA Methylation, Male, Prognosis, Middle Aged, Female, Mutation, Neoplasm Recurrence, Local, Temozolomide, Phenotype, Adult, Aged, Biomarkers, Tumor, Longitudinal Studies, Survival Rate, Follow-Up Studies, Promoter Regions, Genetic, DNA Modification Methylases, Tumor Suppressor Proteins, DNA Repair Enzymes, Oncology & Carcinogenesis, Oncology and carcinogenesis

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/0gg6p5rb
https://escholarship.org/content/qt0gg6p5rb/qt0gg6p5rb.pdf

المؤلفون: ZHANG Xuewen¹, WANG Yu², WU Jie^1,2, WANG Chen^1,2

المصدر: Chinese Journal of Immunology. Nov2024, Vol. 40 Issue 11, p2373-2379. 7p.

مصطلحات موضوعية: *ISOCITRATE dehydrogenase, *TEMOZOLOMIDE, *GLIOMAS, *SURVIVAL rate, *SURGICAL excision

المؤلفون: Shi, Zhi‐Feng^1,2 (AUTHOR), Li, Kay Ka‐Wai³ (AUTHOR), Kwan, Johnny Sheung‐Him^3,4 (AUTHOR), Chung, Nellie Yuk‐Fei³ (AUTHOR), Wong, Sze‐Ching³ (AUTHOR), Chu, Abby Wai‐Yan³ (AUTHOR), Chen, Hong⁵ (AUTHOR), Chan, Danny Tat‐Ming⁶ (AUTHOR), Mao, Ying^1,2 (AUTHOR) maoying@fudan.edu.cn, Ng, Ho‐Keung^2,3 (AUTHOR) hkng@cuhk.edu.hk

المصدر: Brain Pathology. Oct2024, p1. 11p. 6 Illustrations.

مصطلحات موضوعية: *TEMOZOLOMIDE, *ASTROCYTOMAS, *DNA methylation, *DNA sequencing, *GLIOMAS

المؤلفون: Lassaletta, Alvaro¹ (AUTHOR) lassaalvaro@yahoo.com, Zapotocky, Michal² (AUTHOR), Bouffet, Eric³ (AUTHOR)

المصدر: Child's Nervous System. Oct2024, Vol. 40 Issue 10, p3229-3239. 11p.

مصطلحات موضوعية: *CHILD patients, *TEMOZOLOMIDE, *AGE groups, *GLIOMAS, *CANCER chemotherapy

المؤلفون: Ren, Chongwen¹ (AUTHOR), Tu, Qingqing² (AUTHOR), He, Jinchao¹ (AUTHOR) Jinchao_he83@outlook.com

المصدر: Journal of Biomaterials Science -- Polymer Edition. Sep2024, Vol. 35 Issue 13, p1978-1998. 21p.

مصطلحات موضوعية: *DRUG delivery systems, *TEMOZOLOMIDE, *ANTINEOPLASTIC agents, *CANCER cells, *CANCER treatment

المؤلفون: Shetty, Karishma¹ (AUTHOR), Yadav, Khushwant S.¹ (AUTHOR) khush.yadav@gmail.com

المصدر: Drug Development & Industrial Pharmacy. May2024, Vol. 50 Issue 5, p420-431. 12p.

مصطلحات موضوعية: TEMOZOLOMIDE, NANOMEDICINE, GLIOBLASTOMA multiforme, DRUG delivery systems, NANOPARTICLE size, POLYMERSOMES, FACTORIAL experiment designs

المؤلفون: Nationwide Children's Hospital, United Therapeutics, Children's Neuroblastoma Cancer Fund

المصدر: Phase II Study of Ex-Vivo Expanded Allogeneic Universal Donor TGFβi NK Cell Infusions in Combination With Temozolomide, Irinotecan, Dinutuximab, and Sargramostim in Patients With Relapsed or Refractory Neuroblastoma The STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

المصدر: A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma

Other URLs: https://grants.nih.gov/policy/sharing.htm

المصدر: Randomized Phase II Trial on Fitness- and Comorbidity- Tailored Treatment in Elderly Patients With Newly Diagnosed Primary CNS Lymphoma (FIORELLA Trial)

المصدر: An Open-Label, Multicenter, Long-Term Extension Study of Treatment With Tislelizumab, Pamiparib, and Other Investigational Agents in Patients With Advanced Malignancies

Other URLs: https://www.beigenemedical.com/medical-information-request

المؤلفون: Merck Sharp & Dohme LLC

المصدر: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Optune® (TTFields, 200 kHz) Concomitant With Maintenance Temozolomide and Pembrolizumab Versus Optune® Concomitant With Maintenance Temozolomide and Placebo for the Treatment of Newly Diagnosed Glioblastoma (EF-41/KEYNOTE D58).

المصدر: Biomarker Directed Trial of Temozolomide and PARP Inhibition in Relapsed SCLC

المصدر: A Prospective, Randomised, Controlled, Open-label, Multicentre Study to Evaluate Efficacy, Safety and Patient-Reported Outcomes of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-Edotreotide Compared to Best Standard of Care in Patients With Well-differentiated Aggressive Grade 2 and Grade 3, Somatostatin Receptor-Positive (SSTR+), Neuroendocrine Tumours of GastroEnteric or Pancreatic Origin

المؤلفون: National Cancer Institute (NCI)

المصدر: A Phase I Lead-In to a 2x2x2 Factorial Trial of Temozolomide, Memantine, Mefloquine, and Metformin as Post-Radiation Adjuvant Therapy of Glioblastoma Multiforme